Pharmacology Quiz: Laxatives And Antidiarrheals
20 questions · exam conditions
0:00
Laxatives And AntidiarrhealsQuestion 1 of 20

A patient is instructed that their new enteric-coated bisacodyl tablets should not be taken within one hour of consuming milk or antacids. What is the rationale for this instruction?

These substances increase gastric pH, causing premature dissolution of the enteric coating and leading to stomach irritation.
These substances can chelate the active drug, preventing its absorption in the small intestine.
These substances delay gastric emptying, which will significantly delay the onset of the laxative effect.
Bisacodyl requires an acidic environment for activation, which is neutralized by milk and antacids.
← Back to quizzes

Pharmacology Quiz

Pharmacology Quiz: Laxatives And Antidiarrheals

Practice Laxatives And Antidiarrheals in Pharmacology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Laxatives And Antidiarrheals, giving you a quick way to practice the rules, question types, and explanations that matter most for Pharmacology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A patient is instructed that their new enteric-coated bisacodyl tablets should not be taken within one hour of consuming milk or antacids. What is the rationale for this instruction?

  1. These substances increase gastric pH, causing premature dissolution of the enteric coating and leading to stomach irritation. (correct answer)
  2. These substances can chelate the active drug, preventing its absorption in the small intestine.
  3. These substances delay gastric emptying, which will significantly delay the onset of the laxative effect.
  4. Bisacodyl requires an acidic environment for activation, which is neutralized by milk and antacids.
Explanation: When you encounter questions about enteric-coated medications, focus on understanding why the coating exists and what conditions affect its integrity. Enteric coatings are designed to protect drugs from stomach acid and prevent gastric irritation by ensuring the medication dissolves only in the more alkaline environment of the small intestine. Bisacodyl is a stimulant laxative that can cause significant stomach irritation if released in the acidic gastric environment. The enteric coating is formulated to remain intact at the stomach's normal acidic pH (around 1.5-3.5) but dissolve when it reaches the small intestine where pH rises to approximately 6-7. When you consume milk or antacids, they neutralize stomach acid and raise gastric pH above the coating's dissolution threshold. This causes the coating to break down prematurely in the stomach, exposing the gastric mucosa to bisacodyl and potentially causing cramping, nausea, and irritation. Option B is incorrect because bisacodyl doesn't have significant chelation interactions with calcium or magnesium from these sources. Option C is wrong because while these substances might slightly affect gastric emptying, this isn't the primary concern with enteric-coated bisacodyl. Option D reverses the actual mechanism—bisacodyl doesn't require acid for activation; rather, the enteric coating protects it from acid until it reaches its site of action. Remember this pattern: enteric-coated medications + alkaline substances = potential for premature drug release and irritation. Always consider how pH changes affect drug delivery systems when answering pharmacology questions about drug-food interactions.

Question 2

A 68-year-old male with stage 4 chronic kidney disease (eGFR 25 mL/min/1.73m²) presents with constipation. He reports self-treating with a daily over-the-counter liquid laxative for the past week. Today, he presents to the emergency department with lethargy, hyporeflexia, and hypotension. An ECG reveals a prolonged PR interval. Laboratory results are pending, but hypermagnesemia is strongly suspected. Which laxative did the patient most likely consume?

  1. Polyethylene glycol 3350
  2. Lactulose solution
  3. Magnesium hydroxide (correct answer)
  4. Psyllium husk suspension
Explanation: The patient's symptoms (lethargy, hyporeflexia, hypotension, ECG changes) are classic signs of hypermagnesemia. In a patient with severe chronic kidney disease, the ability to excrete magnesium is significantly impaired. Magnesium hydroxide (Milk of Magnesia) is a saline osmotic laxative that contains a substantial amount of magnesium. Its chronic use in this patient population can lead to toxic accumulation. Polyethylene glycol, lactulose, and psyllium are considered much safer alternatives as they do not pose a risk of magnesium accumulation.

Question 3

A patient with irritable bowel syndrome with alternating constipation and diarrhea (IBS-A) is seeking a single over-the-counter agent that could potentially help manage both symptoms. Which property of calcium polycarbophil allows it to be used for both conditions?

  1. It is a hydrophilic agent that absorbs free fecal water in diarrhea and retains water to add bulk during constipation. (correct answer)
  2. It modulates intestinal motility, stimulating slow-transit constipation and inhibiting hypermotile diarrhea.
  3. It alters the gut microbiome, selectively promoting bacterial species that lead to normalized stool consistency.
  4. It functions as a partial agonist at mu-opioid receptors, providing a normalizing effect on gut transit.
Explanation: When you encounter questions about agents that treat seemingly opposite GI conditions, focus on the mechanism of action and how it adapts to different intestinal environments. Calcium polycarbophil is a hydrophilic (water-loving) polymer that works through a single, elegant mechanism: water regulation. In diarrhea, where excess free water is present in the intestinal lumen, the polymer absorbs this water, reducing stool liquidity and firming consistency. Conversely, in constipation, where the colon has absorbed too much water from stool, calcium polycarbophil retains water it has absorbed, adding bulk and moisture to facilitate easier passage. This dual action makes option A correct. Option B incorrectly suggests calcium polycarbophil affects intestinal motility. While motility changes occur in IBS, calcium polycarbophil doesn't directly modulate smooth muscle contractions or gut transit speed—it purely works through physical water management. Option C misrepresents the mechanism as microbiome modulation. Calcium polycarbophil is not a prebiotic or probiotic agent and doesn't selectively alter bacterial populations to normalize stool consistency. Option D incorrectly identifies an opioid mechanism. Medications like loperamide work at mu-opioid receptors to slow transit, but calcium polycarbophil has no opioid activity whatsoever. Study tip: For bulk-forming agents, remember they're "smart" materials that respond to local water conditions. This property distinguishes them from agents that work through receptor binding or metabolic pathways. Always consider the physical chemistry when evaluating polymer-based medications.

Question 4

A 70-year-old patient with congestive heart failure and an eGFR of 40 mL/min/1.73m² requires a bowel preparation for an elective colonoscopy. Why is a large-volume polyethylene glycol-electrolyte solution (PEG-ELS) strongly preferred over a sodium phosphate-based preparation for this patient?

  1. Sodium phosphate has a significantly slower onset of action, prolonging patient discomfort.
  2. PEG-ELS is more effective at cleansing the distal colon, which is the primary area of interest.
  3. Sodium phosphate can cause large fluid shifts and severe electrolyte disturbances, including hyperphosphatemia. (correct answer)
  4. PEG-ELS is significantly more palatable and has a lower incidence of nausea and vomiting.
Explanation: Sodium phosphate preparations are hyperosmotic and can cause significant shifts of fluid from the intravascular space into the gut lumen, posing a risk of dehydration and hypotension. Furthermore, the phosphate load can be absorbed, leading to hyperphosphatemia, hypocalcemia, and hypokalemia, which can precipitate acute kidney injury (acute phosphate nephropathy) and cardiac arrhythmias. These risks are unacceptably high in patients with pre-existing cardiac or renal disease. PEG-ELS is isosmotic and is not absorbed, so it cleanses the bowel without causing significant fluid or electrolyte shifts.

Question 5

A patient taking warfarin for atrial fibrillation is planning a trip and asks about using bismuth subsalicylate for potential traveler's diarrhea. Which is the most critical counseling point regarding a potential drug interaction?

  1. Bismuth may chelate warfarin in the gut, reducing its anticoagulant effect.
  2. The subsalicylate component can displace warfarin from plasma proteins and inhibit platelet function, increasing bleeding risk. (correct answer)
  3. Bismuth subsalicylate induces CYP2C9, leading to accelerated metabolism of warfarin and a subtherapeutic INR.
  4. The medication alkalinizes the urine, which increases the renal clearance of warfarin.
Explanation: Bismuth subsalicylate is hydrolyzed to bismuth and salicylic acid. Salicylates, like aspirin, can increase the risk of bleeding through two main mechanisms: they are highly protein-bound and can displace warfarin from its binding sites on albumin, increasing the free fraction of warfarin; and they have antiplatelet effects by inhibiting cyclooxygenase. This combination can lead to a dangerously elevated INR and increased risk of hemorrhage.

Question 6

A patient who recently underwent a myocardial infarction is prescribed docusate sodium. The patient expresses confusion, stating they are not constipated. What is the most appropriate rationale for prescribing docusate in this clinical scenario?

  1. To stimulate peristalsis, which is often slowed by bed rest and post-operative medications.
  2. To prevent straining during defecation, which can induce a vagal response and cause bradycardia or arrhythmias. (correct answer)
  3. To osmotically draw water into the colon to counteract the constipating effects of opioid analgesics.
  4. To lubricate the intestinal lumen, facilitating easier passage of stool without patient effort.
Explanation: Docusate is a surfactant agent, or stool softener. It does not stimulate peristalsis or have a significant osmotic effect. Its primary role is to allow water and lipids to incorporate into the stool, making it softer and easier to pass. In post-myocardial infarction patients, the primary goal is to prevent straining (Valsalva maneuver), which increases intrathoracic pressure, decreases venous return, and can cause dangerous vagal responses or fluctuations in blood pressure.

Question 7

A 72-year-old woman with hypertension treated with an ACE inhibitor and chronic constipation has found psyllium fiber to be ineffective. Her physician considers adding polyethylene glycol (PEG) 3350. What is the primary reason PEG is a safer choice for this patient compared to a magnesium citrate-based osmotic laxative?

  1. PEG does not cause the significant abdominal bloating and flatulence associated with magnesium-based laxatives.
  2. The patient's use of an ACE inhibitor increases her risk of developing severe hypomagnesemia if given magnesium citrate.
  3. Magnesium citrate directly interferes with the antihypertensive action of ACE inhibitors at the renal tubule.
  4. PEG is minimally absorbed and therefore does not pose a risk of systemic electrolyte disturbances. (correct answer)
Explanation: When evaluating laxative safety in elderly patients with comorbidities, you need to consider both the mechanism of action and potential for systemic absorption. This question tests your understanding of osmotic laxative pharmacokinetics and their clinical implications. PEG 3350 works as an osmotic laxative by drawing water into the intestinal lumen, but crucially, it has minimal systemic absorption. This means it stays in the GI tract and doesn't significantly affect blood electrolyte levels, making it particularly safe for elderly patients who may have compromised kidney function or be taking medications that affect electrolyte balance. Let's examine why the other options are incorrect: Choice A is wrong because both PEG and magnesium-based laxatives can cause similar GI side effects like bloating and gas. This isn't the primary safety distinction between them. Choice B misrepresents the interaction. ACE inhibitors don't increase hypomagnesemia risk with magnesium citrate. If anything, magnesium citrate could potentially increase serum magnesium levels, especially problematic in patients with kidney issues. Choice C is incorrect because magnesium citrate doesn't directly interfere with ACE inhibitor action at the renal tubule. The concern with magnesium-based laxatives is systemic absorption leading to electrolyte imbalances, not direct drug interactions. The key safety advantage of PEG is its minimal absorption profile (choice D). Unlike magnesium citrate, which can be absorbed and cause hypermagnesemia, particularly dangerous in elderly patients with reduced renal clearance, PEG remains in the bowel. Study tip: Remember that for elderly patients, always consider absorption potential when choosing laxatives—non-absorbable options like PEG are generally safer than absorbable osmotic agents.

Question 8

The antidiarrheal medication Lomotil is a combination of diphenoxylate and atropine. What is the primary pharmacological purpose of including a subtherapeutic dose of atropine in this formulation?

  1. To provide a synergistic antidiarrheal effect by reducing intestinal secretions and motility.
  2. To reverse potential respiratory depression caused by the opioid component, diphenoxylate.
  3. To deter abuse and overdose by causing unpleasant anticholinergic effects at higher-than-prescribed doses. (correct answer)
  4. To block muscarinic receptors on gastric parietal cells, thereby reducing acid secretion that may worsen diarrhea.
Explanation: Diphenoxylate is a mu-opioid agonist that can produce euphoria and CNS depression at high doses, giving it abuse potential. Atropine is added in a dose that is too low to have therapeutic effects but is sufficient to cause undesirable anticholinergic side effects (e.g., dry mouth, blurred vision, tachycardia, urinary retention) if the medication is taken in large quantities. This serves as a deterrent to abuse.

Question 9

A patient with a metastatic carcinoid tumor suffers from severe secretory diarrhea and cutaneous flushing. These symptoms are refractory to high-dose loperamide. Which agent is most appropriate for controlling this patient's symptoms by directly targeting their underlying cause?

  1. Cholestyramine
  2. Alosetron
  3. Octreotide (correct answer)
  4. Tincture of opium
Explanation: Carcinoid syndrome is caused by the secretion of vasoactive substances, primarily serotonin and bradykinin, from the tumor. Octreotide is a long-acting synthetic analog of somatostatin, a natural hormone that inhibits the secretion of many other hormones and peptides. By binding to somatostatin receptors on the tumor cells, octreotide directly inhibits the release of serotonin and other mediators, thereby controlling the severe secretory diarrhea and flushing characteristic of the syndrome.

Question 10

An 82-year-old bedridden patient with dysphagia is administered mineral oil daily for chronic constipation. The patient is later hospitalized with a diagnosis of lipoid pneumonia. This complication is a direct consequence of which of the following?

  1. Systemic absorption of mineral oil and subsequent deposition in alveolar tissue.
  2. Aspiration of oil droplets into the tracheobronchial tree during swallowing. (correct answer)
  3. Malabsorption of vitamin K, leading to microhemorrhages in the lungs.
  4. An IgE-mediated hypersensitivity reaction to impurities in the mineral oil.
Explanation: Mineral oil is a lubricant laxative. A major risk associated with its use, especially in elderly, debilitated, or recumbent patients with impaired swallowing (dysphagia), is aspiration. The aspirated oil droplets are not easily cleared by the lungs and lead to a foreign body reaction and chronic inflammation, resulting in lipoid pneumonia. Mineral oil is minimally absorbed systemically. While it can cause malabsorption of fat-soluble vitamins, this does not directly cause lipoid pneumonia.

Question 11

Loperamide is an effective opioid agonist for treating diarrhea that, at therapeutic doses, is notably free of the central nervous system effects typical of other opioids. What is the primary pharmacokinetic mechanism that limits its CNS penetration?

  1. It is a potent substrate for P-glycoprotein, an efflux transporter at the blood-brain barrier. (correct answer)
  2. It undergoes nearly complete first-pass metabolism in the liver to inactive metabolites.
  3. It has extremely high plasma protein binding, preventing it from leaving the circulation.
  4. It selectively targets a subtype of mu-opioid receptor found only in the enteric nervous system.
Explanation: While loperamide can cross the blood-brain barrier, it is actively transported back out into the bloodstream by the P-glycoprotein (P-gp) efflux pump, also known as multidrug resistance protein 1 (MDR1). This transport system effectively prevents loperamide from accumulating in the central nervous system at therapeutic concentrations, thus preventing typical opioid effects like analgesia, euphoria, and respiratory depression.

Question 12

A 68-year-old male with stage 4 chronic kidney disease (eGFR 25 mL/min/1.73m²) presents with constipation. He reports self-treating with a daily over-the-counter liquid laxative for the past week. Today, he presents to the emergency department with lethargy, hyporeflexia, and hypotension. An ECG reveals a prolonged PR interval. Laboratory results are pending, but hypermagnesemia is strongly suspected. Which laxative did the patient most likely consume?

  1. Polyethylene glycol 3350
  2. Lactulose solution
  3. Magnesium hydroxide (correct answer)
  4. Psyllium husk suspension
Explanation: The patient's symptoms (lethargy, hyporeflexia, hypotension, ECG changes) are classic signs of hypermagnesemia. In a patient with severe chronic kidney disease, the ability to excrete magnesium is significantly impaired. Magnesium hydroxide (Milk of Magnesia) is a saline osmotic laxative that contains a substantial amount of magnesium. Its chronic use in this patient population can lead to toxic accumulation. Polyethylene glycol, lactulose, and psyllium are considered much safer alternatives as they do not pose a risk of magnesium accumulation.

Question 13

A 62-year-old male with cirrhosis and hepatic encephalopathy is prescribed lactulose. In addition to its osmotic laxative effect, this medication helps lower systemic ammonia levels. Which mechanism is primarily responsible for this therapeutic effect in hepatic encephalopathy?

  1. Lactulose is metabolized by colonic bacteria to acidic byproducts, which promote the conversion of absorbable ammonia (NH3) to non-absorbable ammonium (NH4+). (correct answer)
  2. Lactulose acts as a chelating agent, directly binding ammonia in the gut lumen and preventing its absorption into the portal circulation.
  3. Lactulose selectively promotes the proliferation of non-urease-producing gut bacteria, thereby decreasing the overall production of ammonia.
  4. Lactulose stimulates pan-colonic motility, which significantly reduces the transit time and thus the time available for ammonia production and absorption.
Explanation: The primary mechanism by which lactulose treats hepatic encephalopathy is through the acidification of the gut lumen. Colonic bacteria metabolize lactulose into lactic acid and other short-chain fatty acids, lowering the colonic pH. This acidic environment favors the conversion of ammonia (NH3), which readily crosses biological membranes, into ammonium (NH4+). Ammonium is a charged ion and is thus 'trapped' in the colon and cannot be absorbed, leading to its excretion in the feces.

Question 14

A 48-year-old woman who underwent a cholecystectomy one year ago presents with chronic, watery diarrhea, often occurring after meals. Loperamide provides only minimal relief. Which medication is most likely to be effective by targeting the underlying pathophysiology of her diarrhea?

  1. Octreotide
  2. Cholestyramine (correct answer)
  3. Bismuth subsalicylate
  4. Diphenoxylate/atropine
Explanation: This patient's presentation is classic for bile acid malabsorption (or bile acid diarrhea), a common complication after cholecystectomy. Without the gallbladder to store and concentrate bile, the continuous flow of bile acids into the intestine can overwhelm the reabsorptive capacity of the terminal ileum. Excess bile acids in the colon act as an osmotic and secretory irritant, causing diarrhea. Cholestyramine is a bile acid sequestrant that binds bile acids in the intestinal lumen, preventing their diarrheagenic effects.

Question 15

A 70-year-old patient with congestive heart failure and an eGFR of 40 mL/min/1.73m² requires a bowel preparation for an elective colonoscopy. Why is a large-volume polyethylene glycol-electrolyte solution (PEG-ELS) strongly preferred over a sodium phosphate-based preparation for this patient?

  1. Sodium phosphate has a significantly slower onset of action, prolonging patient discomfort.
  2. PEG-ELS is more effective at cleansing the distal colon, which is the primary area of interest.
  3. Sodium phosphate can cause large fluid shifts and severe electrolyte disturbances, including hyperphosphatemia. (correct answer)
  4. PEG-ELS is significantly more palatable and has a lower incidence of nausea and vomiting.
Explanation: Sodium phosphate preparations are hyperosmotic and can cause significant shifts of fluid from the intravascular space into the gut lumen, posing a risk of dehydration and hypotension. Furthermore, the phosphate load can be absorbed, leading to hyperphosphatemia, hypocalcemia, and hypokalemia, which can precipitate acute kidney injury (acute phosphate nephropathy) and cardiac arrhythmias. These risks are unacceptably high in patients with pre-existing cardiac or renal disease. PEG-ELS is isosmotic and is not absorbed, so it cleanses the bowel without causing significant fluid or electrolyte shifts.

Question 16

A patient with irritable bowel syndrome with alternating constipation and diarrhea (IBS-A) is seeking a single over-the-counter agent that could potentially help manage both symptoms. Which property of calcium polycarbophil allows it to be used for both conditions?

  1. It is a hydrophilic agent that absorbs free fecal water in diarrhea and retains water to add bulk during constipation. (correct answer)
  2. It modulates intestinal motility, stimulating slow-transit constipation and inhibiting hypermotile diarrhea.
  3. It alters the gut microbiome, selectively promoting bacterial species that lead to normalized stool consistency.
  4. It functions as a partial agonist at mu-opioid receptors, providing a normalizing effect on gut transit.
Explanation: When you encounter questions about agents that treat seemingly opposite GI conditions, focus on the mechanism of action and how it adapts to different intestinal environments. Calcium polycarbophil is a hydrophilic (water-loving) polymer that works through a single, elegant mechanism: water regulation. In diarrhea, where excess free water is present in the intestinal lumen, the polymer absorbs this water, reducing stool liquidity and firming consistency. Conversely, in constipation, where the colon has absorbed too much water from stool, calcium polycarbophil retains water it has absorbed, adding bulk and moisture to facilitate easier passage. This dual action makes option A correct. Option B incorrectly suggests calcium polycarbophil affects intestinal motility. While motility changes occur in IBS, calcium polycarbophil doesn't directly modulate smooth muscle contractions or gut transit speed—it purely works through physical water management. Option C misrepresents the mechanism as microbiome modulation. Calcium polycarbophil is not a prebiotic or probiotic agent and doesn't selectively alter bacterial populations to normalize stool consistency. Option D incorrectly identifies an opioid mechanism. Medications like loperamide work at mu-opioid receptors to slow transit, but calcium polycarbophil has no opioid activity whatsoever. Study tip: For bulk-forming agents, remember they're "smart" materials that respond to local water conditions. This property distinguishes them from agents that work through receptor binding or metabolic pathways. Always consider the physical chemistry when evaluating polymer-based medications.

Question 17

The prescribing information for guanylate cyclase-C agonists like plecanatide includes a black box warning against their use in a specific patient population because of a risk of serious dehydration observed in nonclinical studies. In which population is plecanatide absolutely contraindicated?

  1. Patients with severe renal impairment (eGFR < 30 mL/min)
  2. Patients with known or suspected mechanical gastrointestinal obstruction
  3. Pregnant patients in the third trimester
  4. Pediatric patients under 6 years of age (correct answer)
Explanation: When you encounter questions about black box warnings, focus on the most serious safety concerns that led regulators to require the strongest possible warning. Black box warnings represent life-threatening risks that absolutely contraindicate a drug in certain populations. Plecanatide and other guanylate cyclase-C agonists work by increasing fluid secretion into the intestinal lumen to treat constipation. The FDA requires a black box warning specifically prohibiting use in pediatric patients under 6 years old because nonclinical studies showed severe dehydration and death in young juvenile mice. Children in this age group have a much higher surface area-to-volume ratio and are more susceptible to rapid fluid losses, making the dehydration risk potentially fatal. This makes option D correct. Option A is incorrect because while renal impairment requires monitoring, it's not an absolute contraindication with a black box warning. Option B represents a logical contraindication for any laxative (you wouldn't want to increase intestinal secretions if there's a blockage), but this is a standard contraindication, not the specific black box warning being asked about. Option C is wrong because pregnancy concerns, while important, are not the focus of plecanatide's black box warning. Remember that black box warnings always target the highest-risk populations where drug use could be fatal. When you see questions about these warnings, look for vulnerable populations (often pediatric or elderly patients) where the drug's mechanism of action could cause disproportionate harm. Age-related pharmacokinetic differences frequently drive these serious safety restrictions.

Question 18

A patient is experiencing acute diarrhea after starting a new course of broad-spectrum antibiotics. The physician suspects antibiotic-associated diarrhea, but not C. difficile infection. Which of the following antidiarrheal agents would be least appropriate due to its mechanism of action potentially prolonging the intestinal dysbiosis?

  1. Bismuth subsalicylate
  2. Calcium polycarbophil
  3. Cholestyramine
  4. Loperamide (correct answer)
Explanation: When you encounter questions about antibiotic-associated diarrhea, focus on how different treatments either support or hinder gut microbiome recovery. Antibiotic-associated diarrhea occurs because broad-spectrum antibiotics disrupt normal intestinal flora, creating dysbiosis that reduces the gut's ability to process nutrients and maintain normal motility. Loperamide (D) is least appropriate because it's an opioid receptor agonist that slows intestinal motility by reducing peristalsis. While this decreases diarrhea symptoms, it actually prolongs the underlying problem by allowing pathogenic bacteria to remain in contact with the intestinal wall longer and preventing the natural flushing mechanism that helps restore normal flora balance. The other options work differently and don't impair recovery. Bismuth subsalicylate (A) has antimicrobial properties against pathogenic bacteria while allowing beneficial flora to recover, plus it has anti-inflammatory effects on the intestinal mucosa. Calcium polycarbophil (B) is a bulk-forming agent that absorbs excess water and toxins without affecting motility, helping normalize stool consistency while the microbiome rebalances. Cholestyramine (C) binds bacterial toxins and bile acids, removing harmful substances while permitting natural gut flora restoration. For pharmacology exams, remember that in cases of infectious or antibiotic-related GI disorders, avoid medications that slow gut motility (like loperamide or other opioid-based antidiarrheals) because they can worsen the underlying condition by preventing natural clearance mechanisms from functioning.

Question 19

A 72-year-old woman with hypertension treated with an ACE inhibitor and chronic constipation has found psyllium fiber to be ineffective. Her physician considers adding polyethylene glycol (PEG) 3350. What is the primary reason PEG is a safer choice for this patient compared to a magnesium citrate-based osmotic laxative?

  1. PEG does not cause the significant abdominal bloating and flatulence associated with magnesium-based laxatives.
  2. The patient's use of an ACE inhibitor increases her risk of developing severe hypomagnesemia if given magnesium citrate.
  3. Magnesium citrate directly interferes with the antihypertensive action of ACE inhibitors at the renal tubule.
  4. PEG is minimally absorbed and therefore does not pose a risk of systemic electrolyte disturbances. (correct answer)
Explanation: When evaluating laxative safety in elderly patients with comorbidities, you need to consider both the mechanism of action and potential for systemic absorption. This question tests your understanding of osmotic laxative pharmacokinetics and their clinical implications. PEG 3350 works as an osmotic laxative by drawing water into the intestinal lumen, but crucially, it has minimal systemic absorption. This means it stays in the GI tract and doesn't significantly affect blood electrolyte levels, making it particularly safe for elderly patients who may have compromised kidney function or be taking medications that affect electrolyte balance. Let's examine why the other options are incorrect: Choice A is wrong because both PEG and magnesium-based laxatives can cause similar GI side effects like bloating and gas. This isn't the primary safety distinction between them. Choice B misrepresents the interaction. ACE inhibitors don't increase hypomagnesemia risk with magnesium citrate. If anything, magnesium citrate could potentially increase serum magnesium levels, especially problematic in patients with kidney issues. Choice C is incorrect because magnesium citrate doesn't directly interfere with ACE inhibitor action at the renal tubule. The concern with magnesium-based laxatives is systemic absorption leading to electrolyte imbalances, not direct drug interactions. The key safety advantage of PEG is its minimal absorption profile (choice D). Unlike magnesium citrate, which can be absorbed and cause hypermagnesemia, particularly dangerous in elderly patients with reduced renal clearance, PEG remains in the bowel. Study tip: Remember that for elderly patients, always consider absorption potential when choosing laxatives—non-absorbable options like PEG are generally safer than absorbable osmotic agents.

Question 20

A patient taking warfarin for atrial fibrillation is planning a trip and asks about using bismuth subsalicylate for potential traveler's diarrhea. Which is the most critical counseling point regarding a potential drug interaction?

  1. Bismuth may chelate warfarin in the gut, reducing its anticoagulant effect.
  2. The subsalicylate component can displace warfarin from plasma proteins and inhibit platelet function, increasing bleeding risk. (correct answer)
  3. Bismuth subsalicylate induces CYP2C9, leading to accelerated metabolism of warfarin and a subtherapeutic INR.
  4. The medication alkalinizes the urine, which increases the renal clearance of warfarin.
Explanation: Bismuth subsalicylate is hydrolyzed to bismuth and salicylic acid. Salicylates, like aspirin, can increase the risk of bleeding through two main mechanisms: they are highly protein-bound and can displace warfarin from its binding sites on albumin, increasing the free fraction of warfarin; and they have antiplatelet effects by inhibiting cyclooxygenase. This combination can lead to a dangerously elevated INR and increased risk of hemorrhage.